am-LOE-di-peen
Therapeutic Classification: antianginals, antihypertensives
Pharmacologic Classification: calcium channel blockers
REMS
Absorption: Well absorbed after oral administration (64–90%).
Distribution: Probably crosses the placenta.
Protein Binding: 95–98%.
Half-Life: 30–50 hr (↑ in geriatric patients and patients with hepatic impairment).
Contraindicated in:
Use Cautiously in:
CV: peripheral edema, angina, bradycardia, hypotension, palpitations
Derm: flushing
GI: gingival hyperplasia, nausea
Drug-drug:
Hepatic Impairment
Lab Test Considerations:
NDC Code
